Evidence map›Paper›PMID 22220752›Full record

ArticleJournal of neurochemistry2012

The Cbln family of proteins interact with multiple signaling pathways.

Peng Wei, Roberto Pattarini, Yongqi Rong, Hong Guo, Parmil K Bansal, Sheila V Kusnoor, Ariel Y Deutch, Jennifer Parris, James I Morgan

Abstract read
In one paragraph

Article in Journal of neurochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Review
  3. Glutamate Delta 1 Receptor in Synapses, Circuits, and Disease.The European journal of neuroscience · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Differential Expression Analysis Identifies Candidate Synaptogenic Molecules for Wiring Direction-Selective Circuits in the Retina.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  8. Cbln1 Directs Axon Targeting by Corticospinal Neurons Specifically toward Thoraco-Lumbar Spinal Cord.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  9. Article
  10. Article
  11. Transsynaptic cerebellin 4-neogenin 1 signaling mediates LTP in the mouse dentate gyrus.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Peng WeiDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN 38105-3678, USA.
Roberto Pattarini
Yongqi Rong
Hong Guo
Parmil K Bansal
Sheila V Kusnoor
Ariel Y Deutch
Jennifer Parris
James I Morgan
St. Jude Children's Research Hospital · USNashville Oncology Associates · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GERARD PAUL ZAMBETTI · 1985 to 2026
$166.9M
Training in Fundamental NeuroscienceT32MH064913 · NIMH · VANDERBILT UNIVERSITY · PI IHRIE, REBECCA A, WINDER, DANNY G. · 2001 to 2022
$7.6M
Regulation of striatal plasticity by phosphatasesP01NS044282 · NINDS · VANDERBILT UNIVERSITY · PI DEUTCH, ARIEL Y · 2002 to 2006
$5.0M
Dopaminergic Regulation of Pyramidal CellsR01MH077298 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DEUTCH, ARIEL Y · 2007 to 2016
$3.6M
Characterizing novel adult neuronal survival factorsR01NS042828 · NINDS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI MORGAN, JAMES I · 2005 to 2009
$1.7M
Mechanisms of Cell Death in the Nervous SystemR01NS040361 · NINDS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI MORGAN, JAMES I · 2001 to 2004
$1.2M
NCI NIH HHS CA 21765NCI NIH HHS P30 CA021765NIMH NIH HHS MH-077298NIMH NIH HHS R01 MH077298NIMH NIH HHS T32 MH064913NINDS NIH HHS NS040361NINDS NIH HHS NS042828NINDS NIH HHS NS44282NINDS NIH HHS P01 NS044282NINDS NIH HHS R01 NS040361NINDS NIH HHS R01 NS042828
6 · The paper itself

Abstract

Cerebellin precursor protein (Cbln1) is essential for synapse integrity in cerebellum through assembly into complexes that bridge pre-synaptic β-neurexins (Nrxn) to post-synaptic GluRδ2. However, GluRδ2 is largely cerebellum-specific, yet Cbln1 and its little studied family members, Cbln2 and Cbln4, are expressed throughout brain. Therefore, we investigated whether additional proteins mediate Cbln family actions. Whereas Cbln1 and Cbln2 bound to GluRδ2 and Nrxns1-3, Cbln4 bound weakly or not at all, suggesting it has distinct binding partners. In a candidate receptor-screening assay, Cbln4 (but not Cbln1 or Cbln2) bound selectively to the netrin receptor, (deleted in colorectal cancer (DCC) in a netrin-displaceable fashion. To determine whether Cbln4 had a netrin-like function, Cbln4-null mice were generated. Cbln4-null mice did not phenocopy netrin-null mice. Cbln1 and Cbln4 were likely co-localized in neurons thought to be responsible for synaptic changes in striatum of Cbln1-null mice. Furthermore, complexes containing Cbln1 and Cbln4 had greatly reduced affinity to DCC but increased affinity to Nrxns, suggesting a functional interaction. However, Cbln4-null mice lacked the striatal synaptic changes seen in Cbln null mice. Thus, Cbln family members interact with multiple receptors/signaling pathways in a subunit composition-dependent manner and have independent functions with Cbln4 potentially involved in the less well-characterized role of netrin/DCC in adult brain.

Indexed as

AnimalsBlotting, WesternBrainMiceMice, KnockoutNerve Tissue ProteinsNeuronsProtein PrecursorsReverse Transcriptase Polymerase Chain ReactionSignal TransductionNerve Tissue ProteinsProtein Precursors

Identifiers

PMID22220752
PMCPMC3342465
OpenAlexW1569329096

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.